MVA-BN booster vaccine follow-up
Part of Infections clinical trials.
This study follows people who get a booster dose of the MVA-BN smallpox vaccine. It checks how the body responds and helps researchers understand the vaccine's effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to get a booster dose of the MVA-BN vaccine.
- You are 18 years old or older.
- You agree to give written permission to join the study.
- You are willing to follow the study schedule.
- You have not had a past or current mpox (monkeypox) infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an MVA-based vaccine (MVA-SIBP) to see if it is safe and creates a good immune response against smallpox and mpox. It's for healthy people in certain age groups who have not had these vaccines or infections before.
This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
This study tests how well a booster dose of the MVA-BN mpox vaccine keeps working over time in men who are on or starting PrEP for HIV prevention.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
Hear when a new Monkeypox (Mpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.